uniQure accelerates delivery of transformational gene therapies to patients  

The challenge

UniQure is at the forefront of developing innovative gene therapies designed to treat serious genetic diseases. With a commitment to transforming the lives of patients, uniQure needed a solution to streamline its review and approval processes. We helped them adopt a collaborative document review platform that has transformed how uniQure operates, helping them bring life-changing therapies to patients more efficiently.  

As a pioneering company in the field of gene therapy, uniQure faced the immense challenge of managing and reviewing complex regulatory documentation, including issues with version control, administrative burdens, and unfocused reviewers. The traditional manual review process was time-consuming, error-prone, and often resulted in delays that could impact the delivery of critical therapies to patients.  

The solution

UniQure sought a robust solution that could handle the complexities of their review process while ensuring efficiency and compliance. After evaluating several options, Ideagen PleaseReview stood out for its advanced collaborative features and user-friendly interface.

The implementation

Upon implementing Ideagen PleaseReview, uniQure experienced immediate benefits.   

• Enabling simultaneous document review and secure version control  
• Offering comprehensive audit trails and automated reconciliation reports  
• Reducing the time spent on consolidating feedback  
• Allowing real-time guidance for reviewers to focus on critical sections  

The outcome

With Ideagen PleaseReview, uniQure achieved:  

• 65% faster review times by enhancing collaboration and automating review cycles.
• 30% increase in productivity as improved efficiency freed up time for critical tasks.
• Enhanced compliance with robust tracking and audit capabilities, ensuring seamless regulatory adherence.